Your browser doesn't support javascript.
loading
Validation of the Antifungal National Antimicrobial Prescribing Survey (AF-NAPS) quality assessment tool.
Khanina, A; Douglas, A P; Yeoh, D K; So, M; Abbotsford, J; Spelman, T; Kong, D C M; Slavin, M A; Thursky, K A.
Afiliação
  • Khanina A; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, Victoria 3000, Australia.
  • Douglas AP; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria 3010, Australia.
  • Yeoh DK; Department of Infectious Diseases, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, Victoria 3000, Australia.
  • So M; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, Victoria 3000, Australia.
  • Abbotsford J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria 3010, Australia.
  • Spelman T; Department of Infectious Diseases, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, Victoria 3000, Australia.
  • Kong DCM; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, Victoria 3000, Australia.
  • Slavin MA; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria 3010, Australia.
  • Thursky KA; Department of Infectious Diseases, Perth Children's Hospital, 15 Hospital Ave, Nedlands, Western Australia 6009, Australia.
J Antimicrob Chemother ; 78(6): 1367-1377, 2023 06 01.
Article em En | MEDLINE | ID: mdl-37038993
ABSTRACT

BACKGROUND:

The Antifungal National Antimicrobial Prescribing Survey (AF-NAPS) was developed to undertake streamlined quality audits of antifungal prescribing. The validity and reliability of such tools is not characterized.

OBJECTIVES:

To assess the validity and reliability of the AF-NAPS quality assessment tool.

METHODS:

Case vignettes describing antifungal prescribing were prepared. A steering group was assembled to determine gold-standard classifications for appropriateness and guideline compliance. Infectious diseases physicians, antimicrobial stewardship (AMS) and specialist pharmacists undertook a survey to classify appropriateness and guideline compliance of prescriptions utilizing the AF-NAPS tool. Validity was measured as accuracy, sensitivity and specificity compared with gold standard. Inter-rater reliability was measured using Fleiss' kappa statistics. Assessors' responses and comments were thematically analysed to determine reasons for incorrect classification.

RESULTS:

Twenty-eight clinicians assessed 59 antifungal prescriptions. Overall accuracy of appropriateness assessment was 77.0% (sensitivity 85.3%, specificity 68.0%). Highest accuracy was seen amongst specialist (81%) and AMS pharmacists (79%). Prescriptions with lowest accuracy were in the haematology setting (69%), use of echinocandins (73%), mould-active azoles (75%) and for prophylaxis (71%). Inter-rater reliability was fair overall (0.3906), with moderate reliability amongst specialist pharmacists (0.5304). Barriers to accurate classification were incorrect use of the appropriateness matrix, knowledge gaps and lack of guidelines for some indications.

CONCLUSIONS:

The AF-NAPS is a valid tool, assisting assessors to correctly classify appropriate prescriptions more accurately than inappropriate prescriptions. Specialist and AMS pharmacists had similar performance, providing confidence that both can undertake AF-NAPS audits to a high standard. Identified reasons for incorrect classification will be targeted in the online tool and educational materials.
Assuntos

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Anti-Infecciosos / Antifúngicos Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Anti-Infecciosos / Antifúngicos Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália